PIK3CA and breast cancer: At the same time, the combination of Claudin and EpCAM increases, promotes the phosphorylation of PI3K/Akt and p38, promotes the activation of MAPK and PI3K/Akt pathways, promotes the process of EMT, reduces Apoptotic ability of breast cancer cells, promoting cell proliferation (106).